People Directory : Dave Knaack

SHARE THIS:

Dave Knaack

Director, Technology Transfer

Office for Technology Transfer

Office Phone: +1 508 289 3556

dknaack@whoi.edu

» Lab/Group Site

WHOI Mailing Address:

Woods Hole Oceanographic Institution

266 Woods Hole Rd.

MS# 53

Woods Hole, MA 02543-1050

Research Statement

ISSUED US PATENTS


  PAT. NO.   Title
1 9,789,223  
Polyurethanes for osteoimplants 
2 9,333,080  
Injectable and moldable bone substitute materials 
3 9,327,052  
Polyurethanes for osteoimplants 
4 9,107,751  
Injectable and moldable bone substitute materials 
5 8,771,719  
Synthesis of a bone-polymer composite material 
6 8,740,987  
Tissue-derived mesh for orthopedic regeneration 
7 8,686,064  
Coupling agents for orthopedic biomaterials 
8 8,545,864  
Hemostatic bone graft 
9 8,425,893  
Polyurethanes for osteoimplants 
10 8,333,985  
Non-glycerol stabilized bone graft 
11 8,002,843  
Polyurethanes for osteoimplants 
12 7,985,414  
Polyurethanes for osteoimplants 
13 7,959,941  
Bone graft comprising a demineralized bone matrix and a stabilizing agent 
14 7,270,813  
Coupling agents for orthopedic biomaterials 
15 7,163,691  
Bone graft 
16 6,599,516  
Malleable implant containing solid element that resorbs or fractures to provide access channels 
17 5,773,255  
Glucose responsive insulin secreting .beta.-cell lines and method for producing same 
18 5,712,159  
Glucose responsive insulin secreting .beta.-cell lines and method for producing same 
19 5,534,404  
Glucose responsive insulin secreting .beta.-cell lines and method for producing same 

Personal Statement

David Knaack, Ph.D. joined WHOI in 2013 as the Director for Technology Transfer with responsibilities for Commercializing New Technologies arising from WHOI’s relationship with the sea. In addition to marketing and licensing of new technologies, his role includes identifying, patenting and facilitating applied research for product advancement

Dr. Knaack joined WHOI after 24 years in the Medical Device/Biotech industry where he held leadership positions in Product Development and Research, most recently as Vice President of Product Development & Manufacturing at ORTHOCON/ABYRX, Inc.  His roles in four biomedical startups have given him a breadth of experience in product development, quality systems, regulatory, project management and the strategic development and commercialization of intellectual property.  His areas of technical expertise include: implantable medical devices, biomaterials and composites, biologically active molecules, polymer-tissue composites, and cell line development. He has expertise in a number of therapeutic areas including Diabetes, neurodegeneration, orthopedics, analgesia and hemostasis. Dr. Knaack has peer reviewed publications in the fields of biocomposites, biomaterials, tissue engineering and cell and molecular biology. He is is a registered patent agent, a named inventor on nineteen issued U.S. patents, and agent of record on two others. He holds a B.Sci. in Chemistry from St. Lawrence University and a Ph.D. in Neurochemistry from Cornell University. He completed post-doctoral work in Molecular Biology at Harvard Medical School as a Howard Hughes Fellow.

[back]